Ferguson Wellman Capital Management Inc. Invests $810,000 in The Clorox Company $CLX

Ferguson Wellman Capital Management Inc. bought a new stake in The Clorox Company (NYSE:CLX) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 6,568 shares of the company’s stock, valued at approximately $810,000.

Several other hedge funds have also added to or reduced their stakes in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Clorox by 147.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock worth $104,107,000 after purchasing an additional 421,453 shares in the last quarter. Caxton Associates LLP bought a new stake in Clorox in the 1st quarter valued at about $580,000. Woodline Partners LP grew its position in shares of Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after purchasing an additional 7,465 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock worth $170,406,000 after purchasing an additional 41,485 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction dated Friday, November 21st. The stock was bought at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Stock Performance

NYSE:CLX opened at $106.20 on Friday. The Clorox Company has a twelve month low of $96.66 and a twelve month high of $164.22. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The stock’s 50-day simple moving average is $103.00 and its 200 day simple moving average is $115.67. The firm has a market capitalization of $12.95 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 0.52 and a beta of 0.58.

Clorox (NYSE:CLX) last issued its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the previous year, the firm earned $1.86 earnings per share. The business’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a yield of 4.7%. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CLX shares. TD Cowen cut their price target on Clorox from $117.00 to $108.00 and set a “hold” rating for the company in a research note on Thursday. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Wells Fargo & Company decreased their price target on Clorox from $117.00 to $108.00 and set an “equal weight” rating on the stock in a research report on Monday. Jefferies Financial Group reaffirmed a “buy” rating and set a $152.00 price objective on shares of Clorox in a research report on Tuesday, November 4th. Finally, BNP Paribas Exane reduced their price objective on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus target price of $122.88.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.